INTERCEPT PHARMACEUTICALS INC·4

Aug 24, 9:00 PM ET

INTERCEPT PHARMACEUTICALS INC 4

4 · INTERCEPT PHARMACEUTICALS INC · Filed Aug 24, 2015

Insider Transaction Report

Form 4
Period: 2015-08-20
Transactions
  • Exercise/Conversion

    Common Stock

    2015-08-20$9.82/sh+865$8,4961,936 total
  • Sale

    Common Stock

    2015-08-20$206.85/sh974$201,472962 total
  • Exercise/Conversion

    Options to Purchase Common Stock

    2015-08-201090 total
    Exercise: $9.82Exp: 2018-09-18Common Stock (109 underlying)
  • Exercise/Conversion

    Options to Purchase Common Stock

    2015-08-208653,894 total
    Exercise: $9.82Exp: 2019-09-16Common Stock (865 underlying)
  • Exercise/Conversion

    Common Stock

    2015-08-20$9.82/sh+109$1,0711,071 total
Footnotes (2)
  • [F1]The reported transaction was made pursuant to a 10(b)5-1 plan adopted by the reporting person on November 21, 2014.
  • [F2]All shares underlying this option have vested.

Documents

1 file
  • 4
    v418957_4.xmlPrimary

    OWNERSHIP DOCUMENT